Categories Editor's Pick

Lilly’s weight-loss treatment Zepbound becomes first FDA-approved drug for sleep apnea

December 21, 2024

By Bhanvi Satija (Reuters) -The U.S. Food and Drug Administration on Friday approved Eli Lilly (NYSE:LLY)’s weight-loss treatment, Zepbound, for obstructive sleep apnea,

Categories Editor's Pick

US finalizes up to $6.75 billion in chips awards for Samsung, Texas Instruments, Amkor

December 21, 2024

By David Shepardson WASHINGTON (Reuters) -The U.S. Commerce Department said on Friday it was finalizing an award of up to $4.745 billion to

Categories Editor's Pick

House Democrat says Republicans protecting Elon Musk’s Chinese investments

December 21, 2024

By David Shepardson WASHINGTON (Reuters) -The top Democrat on the House of Representatives Appropriations Committee said on Friday that Republicans in Congress were